111 INC. ADR/2 CL.A WKN: A2N465 ISIN: US68247Q1022 Kürzel: YI Forum: Aktien Thema: Hauptdiskussion

SHANGHAI , March 2, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China , today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2022 ended December 31, 2022, before the U.S. market opens on Thursday, March 23, 2023.

BEIJING, Dec 13 (Reuters) - Chinese healthcare company 111.inc has started selling Pfizer's Paxlovid for COVID treatment in China for 2,980 yuan per box on its app, the sales page on the app showed. People who test positive for COVID-19 can purchase the oral treatment medication Paxlovid on the app after submitting a positive test result. (Reporting by Beijing newsroom; Editing by Andrew Heavens)